康复新液联合奥美拉唑治疗非幽门螺杆菌感染消化性溃疡的临床效果

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (35 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the clinical efficacy of Rehabilitation New Liquid combined with Omeprazole in the treatment of non-Helicobacter pylori infection peptic ulcer.Methods Altogether 84 patients with peptic ulcer who met the requirements in Affiliated Hospital of Jiujiang University from January 2017 to April 2018 were selected as subjects and randomly divided into case group and control group,with 42 cases in each group.The control group was treated with Omeprazole,while the case group was treated with Rehabilitation New Liquid combined with Omeprazole.The clinical effects of the two groups were observed and compared.The levels of inflammatory cytokines were measured before and after treatment in both groups.The adverse reactions of the two groups were compared.The recurrence of gastric ulcer was compared between the two groups during follow-up.Results The total effective rate of the patients in the case group was 95.24%,which was higher than that in the control group (78.57%),and the difference was statistically significant(P＜0.05).The levels of interleukin-6(IL-6),tumor necrosis factor α (TNF-α)and C-reactive protein(CRP)in the two groups before treatment were not statistically significant(P＞0.05),while the levels of IL-6,TNF-α and CRP after treatment were lower than before treatment,and the differences were statistically significant(P＜0.05).The levels of IL-6,TNF-α and CRP in the case group after treatment were lower than those in the control group,and the differences were statistically significant(P＜0.05).There was no statistically significant difference in the overall incidence of adverse reactions between the two groups(P＞0.05).Gastroscopy review after 2 months of follow-up showed that the recurrence rate of patients in the case group(4.76%)was lower than that in the control group(19.05%),and the difference was statistically significant(P＜0.05).Conclusion Rehabilitation New Liquid combined with Omeprazole is effective in the treatment of peptic ulcer,which has synergistic effect and is worthy of clinical promotion.

Key words： Rehabilitation New Liquid Omeprazole non-Helicobacter pylori infection Peptic ulcer

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors

Cite this article:

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2019/V26/I3/117

[1]	戴孟，郑逢民，叶方益.康复新液联合埃索美拉唑镁治疗消化道溃疡的临床研究[J].中国临床药理学杂志，2016，32（17）：1543-1545.
[2]	杨艺，孟宪生.消化性溃疡的研究进展[J].世界中医药，2017，12（4）：951-955.
[3]	王明会.康复新液联合泮托拉唑用于消化性溃疡治疗的优越性分析[J].中国实用医药，2018，13（10）：118-119.
[4]	陈烨，边佳.健胃愈疡片联合奥美拉唑治疗消化性溃疡的效果及对血浆胃泌素、TGF-α和EGF的影响研究[J].西北国防医学杂志，2018，39（1）：32-35.
[5]	刘容，嵇宏亮.康复新液联合质子泵抑制剂三联疗法治疗消化性溃疡的 Meta 分析[J].浙江中医杂志，2016，51（5）：385-386.
[6]	潘隽峰，潘爱祖.雷贝拉唑联合康复新液治疗老年消化性溃疡的临床疗效分析[J].内蒙古中医药，2017，36（6）：71-72.
[7]	张咏华，李玲，周佳美，等.康复新液、凝血酶冻干粉联合奥美拉唑治疗消化性溃疡出血的临床疗效及纤维蛋白原变化分析[J].现代消化及介入诊疗，2016，21（2）：222-224.
[8]	宋海霞.奥美拉唑治疗消化性溃疡对患者血清IL-6和IL-8水平的影响[J].临床医药文献电子杂志，2016，3（10）：1969.
[9]	魏金宝.泮托拉唑和奥美拉唑治疗消化性溃疡的临床疗效分析[J].首都食品与医药，2017，24（2）：41.
[10]	梁辰飞.温胆汤加味联合奥美拉唑治疗消化性溃疡的疗效观察和代谢组学变化[J].四川中医，2017，35（5）：97-98.
[11]	蒲海翔，何文.雷贝拉唑钠联合奥美拉唑治疗消化性溃疡的临床疗效研究[J].北方药学，2017，14（4）：107.
[12]	陈春柳.康复新液联合奥美拉唑，阿莫西林胶囊三联疗法治疗消化性溃疡的临床研究[J].基层医学论坛，2017，21（13）：1635-1636.
[13]	李秀丽.康复新液、凝血酶冻干粉与奥美拉唑联用方案治疗消化性溃疡出血的临床评价[J].中国现代药物应用，2016，10（22）：112-113.
[14]	杨晓梅.康复新液结合常规疗法治疗消化性溃疡的临床效果及安全性分析[J].基层医学论坛，2016，20（19）：2626-2627.
[15]	何彦锋.康复新液治疗消化性溃疡的疗效观察及评定[J].中国现代药物应用，2018，12（12）：114-116.